Menu
ncarol.com
  • Home
  • Education
  • Health
  • Books
  • Technology
  • Financial
  • Entertainment
  • Real Estate
  • Music
ncarol.com

Stratum Nutrition® Extends Its Patent Portfolio to Europe and Canada
ncarol.com/10174540

Trending...
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
26-171491
CARTHAGE, Mo. - ncarol.com -- Stratum Nutrition is pleased to announce that ESM Technologies, LLC recently received Notices of Allowance for two different patents in two new geographic regions.

One of the patents, 'Methods for Treating NF-kB Dysregulation in a Host in Need Thereof Using Eggshell Membrane Compositions' was first issued in the U.S. in 2019 (US 10,328,104) and has recently been allowed by the European Patent Office.  This invention deals with a whole host of conditions and diseases related to NF-kB dysregulation including: pulmonary, gastrointestinal, cardiovascular, & nervous system.

The other patent, 'Method for Evaluating Articular Joint Therapeutics' was first issued in the U.S. in 2018 (US 9,983,214) and has recently been allowed by the Canadian Intellectual Property Office.  This invention deals with a clinical trial design using the cartilage degradation biomarker CTX-II to evaluate articular joint therapeutics for chondroprotective efficacy.  Both patents are still pending in multiple additional jurisdictions.

"We are excited to extend our patent protection to additional geographies.  This is particularly true for our CTX-II clinical model patent, which has now been allowed in the U.S., Europe, Canada, Japan, and several other countries.  We have used this patented model in multiple clinical trials to demonstrate that our flagship ingredient, NEM® brand eggshell membrane, helps to protect cartilage in exercising individuals.", said Kevin Ruff, Stratum's Sr. Director of Scientific & Regulatory Affairs.

More on ncarol.com
  • Captain Notepad Launches Full-Service Direct Mail Platform for Small Businesses Nationwide
  • World Cup Buzz Fuels Nayarit's Rise as Mexico's Pacific Standout
  • Nayarit strengthens its position in Mexico's Culinary Elite with 8 restaurants in the 2026 Mexico Gastronomic Guide
  • Winter Garden Ski Lake Home Sells for $2.05M in Cash Transaction, Highlighting Demand for Strategically Positioned Luxury Properties
  • Strobert Tree Services' "50 Shades of Green" Campaign Encourages Arbor Day Action Across Delaware and Pennsylvania

For more information about Stratum Nutrition® and its branded ingredients, please visit www.stratumnutrition.com.

###

About Stratum Nutrition

Stratum Nutrition®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM® brand eggshell membrane, ESC® brand eggshell calcium, Ahiflower® plant-based omegas-3,6,9, Curcumin 95, curQplus™, LBiome™ Lactobacillus LB postbiotic, NatAxtin™ astaxanthin, as well as oral health probiotics, BLIS K12® and BLIS M18®. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.

Contact
Jacqueline Rizo
***@stratumnutrition.com


Source: Stratum Nutrition
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • GDE Tree Services Expands Operations Across Logan, Ipswich and the Gold Coast
  • UK AltNet FullFibre Solves IPv4 Shortage With netElastic BNG And CGNAT Networking Software
  • Studica Robotics Receives 2026 Partner Excellence Award from FIRST® Robotics Canada
  • Seven Games That Make You Think (and Smile) Earn 2026 Mensa Select® Honors
  • New Research Reveals Gen Z Trusts Independent Sources Over Influencers — Exposing What We are Talker Calls "The Independent Validation Gap"
  • New research identifies The Discovery Gap: Seven in 10 Americans say travel is no longer just about getting away
  • PropAccount.com Adds Equities to Its Multi-Asset Prop Firm Platform, Opening the Door to the World's Largest Trading Market
  • Ailias Launches Global Partner Programme for AI-Powered Conversational Digital Humans in Events and Experiences
  • Village People Headline "Rock The Rainbow" Phuket Pride Finale 2026
  • SilverBow Strategies Launches RFPArchon™, the First Product in Its Artemis AI Solutions™ Suite
  • New from Regal House Publishing, The Unfinished Business, its tricky inheriting a ghost-busting firm
  • Sawasdee Anime Launches Animenture: A Gamified SNS Connecting Global Fans to 2,000+ Anime Sites
  • "LOOK UP CAFE TOKYO SKYTREE" to Open on May 22, 2026 on the 5th floor of TOKYO SKYTREE®. This Date also Marks TOKYO SKYTREE's 14th Anniversary
  • "Rehabilitative Prison Program Compromised by Alleged Staff Misconduct, Whistleblower Claims"
  • Creator Space LA brings together industry leaders for an immersive AI showcase, demonstrations, and film hackathon
  • The Hardest Part of Building an App Isn't Starting - It's Finishing
  • Uxur Taxi Unveils Luxury 3,000‑Mile Private Driver Service for Nationwide Travel
  • Colorfront Launches New Mac App For Creating Apple Immersive Video
  • Michele Mundy's "Divinely Tailored" Gains Momentum
  • Evermore Bliss Launches AI Wedding Speech Writer to Help Users Create Personalized, Heartfelt Toasts
_catLbl0 _catLbl1

Popular on ncarol.com

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 365
  • Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets - 147
  • Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
  • Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
  • UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
  • Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)

Similar on ncarol.com

  • Deborah E. Jones Releases Emotional Sovereignty, a Book on Emotional Awareness and Self-Regulation
  • As Fluoride Debate Grips the Nation, Americans Turn to Whole-House Fluoride Filters for Answers
  • Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
  • Studica Robotics Receives 2026 Partner Excellence Award from FIRST® Robotics Canada
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Go Dental Clinic Announces Upcoming Opening of New Branch in International City, Dubai
  • Contracting Resources Group and Aalis Management Consulting Launch ARG Joint Venture Under SBA Mentor-Protégé Program
  • EduCare Inc. Bridges Critical Gap in Breast Cancer Education with Spanish COPE Library Launch
  • Engineering leaders from industry, academia to gather at IISE Annual Conference & Expo in Arlington, Texas
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute